We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A 3D model of a human brain.

Hidden Brain Region May Unlock New Epilepsy Treatment

Cell therapy.

Cell Therapy Treatment Effectively Treats Immune-Compromised Children

A selection of diabetes monitoring and treatment neccessities.

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

Immunotherapy After Kidney Cancer Surgery Improves Overall Survival

Cannabinols Show Neuroprotective Properties in Fruit Flies

News

Illumina Announces Strategic Collaboration with Merck Serono

Collaboration to expand companion diagnostics for oncology.

Recipharm Appoints New Position of Vice President Quality Management

Appointment of Thomas Beck with effect from 1st April 2015.

MorphoSys and Emergent BioSolutions Initiate Phase 1 Clinical Study

Phase 1 study to evaluate the novel oncology immunotherapeutic MOR209/ES414 for prostate cancer.

Alkermes Appoints Mark Namchuk

Dr. Namchuk appointed as Senior Vice President of research, pharmaceutical and nonclinical development.

Using Human Stem Cells To Identify Dangerous Side Effects Of Drugs

Scientists have developed a test that uses cells from a single donor's blood to predict whether a new drug will cause a severe reaction in humans.

Hearts On A Chip To Aid Drug Screening

UC Berkeley bioengineers have developed a heart-on-a-chip which can be used for drug safety screening.

ChemInteract Consortium Wins Funding to Develop Chemical Toxicity Assessment Tool

New technology aims to reduce animal testing and improve safety testing of chemicals.

TSRI Scientists Find Clues to Cancer Drug Failure

A pair of studies show how the primary protein responsible for multidrug chemotherapy resistance changes shape.

Fidelta Achieves Milestone in Collaboration with LEO Pharma

Next phase of the project will contribute significantly to Fidelta's revenues in 2015.

Alizé Pharma Launches Phase II Clinical Trial of AZP-531 in Prader-Willi Syndrome

Results are expected to be available by mid-2016.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter